Katherine Haye Walker, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Viruses | 1 | 2021 | 168 | 0.700 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2023 | 365 | 0.690 |
Why?
|
| Docosahexaenoic Acids | 3 | 2023 | 914 | 0.590 |
Why?
|
| Lipoxins | 3 | 2020 | 419 | 0.280 |
Why?
|
| Pneumonia, Viral | 2 | 2023 | 3238 | 0.280 |
Why?
|
| Lung | 2 | 2021 | 10099 | 0.250 |
Why?
|
| Lim Kinases | 1 | 2020 | 8 | 0.180 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 149 | 0.170 |
Why?
|
| Administration, Intranasal | 1 | 2021 | 485 | 0.170 |
Why?
|
| ADAM Proteins | 1 | 2020 | 242 | 0.160 |
Why?
|
| Macrophages, Alveolar | 1 | 2020 | 415 | 0.150 |
Why?
|
| Hospice Care | 1 | 2024 | 678 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 500 | 0.140 |
Why?
|
| Cytoskeleton | 1 | 2020 | 1179 | 0.120 |
Why?
|
| Pneumonia, Bacterial | 1 | 2018 | 320 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 542 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2021 | 1143 | 0.100 |
Why?
|
| Viral Load | 1 | 2021 | 3396 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2211 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2018 | 2493 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1892 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 1399 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2163 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2018 | 1944 | 0.070 |
Why?
|
| Inflammation | 3 | 2023 | 10873 | 0.070 |
Why?
|
| Mitochondria | 1 | 2020 | 3681 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4648 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3252 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 7951 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7454 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7876 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 82029 | 0.050 |
Why?
|
| Animals | 5 | 2023 | 169246 | 0.040 |
Why?
|
| Immunity, Innate | 2 | 2023 | 3080 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 605 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2024 | 792 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 260 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2023 | 1247 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2023 | 2614 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14488 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 733 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2020 | 1965 | 0.030 |
Why?
|
| Terminal Care | 1 | 2024 | 1770 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2062 | 0.020 |
Why?
|
| Length of Stay | 1 | 2024 | 6498 | 0.020 |
Why?
|
| Male | 3 | 2024 | 364719 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2024 | 3857 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19015 | 0.010 |
Why?
|
| Hospitalization | 1 | 2024 | 10840 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15597 | 0.010 |
Why?
|
| Humans | 6 | 2024 | 768166 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8748 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18349 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22379 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 59629 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23645 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 171504 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 223492 | 0.010 |
Why?
|
| Female | 1 | 2024 | 397192 | 0.000 |
Why?
|